📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial. (2018)

First Author: Sinkala E

Attributed to: Step-down affordable treatment for chronic hepatitis B infection in Africa and India Acronym - STEP-HEP funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4269/ajtmh.17-0637

PubMed Identifier: 29436337

Publication URI: http://europepmc.org/abstract/MED/29436337

Type: Journal Article/Review

Volume: 98

Parent Publication: The American journal of tropical medicine and hygiene

Issue: 4

ISSN: 0002-9637